Trade Phio Pharmaceuticals Corp. - PHIO CFD
Add to favourite- Summary
- Historical Data
| Spread | 0.25 | ||||||||
|
Long position overnight fee
Long position overnight funding adjustment
Go to platform | -0.02629% | ||||||||
|
Short position overnight fee
Short position overnight funding adjustment
Go to platform | 0.004068% | ||||||||
| Overnight fee time | 21:00 (UTC) | ||||||||
| Min traded quantity | 1 | ||||||||
| Currency | USD | ||||||||
| Margin | 5.00% | ||||||||
| Stock exchange | United States of America | ||||||||
| Commission on trade | 0% |
| Prev. Close | 3.75 |
| Open | 3.9 |
| 1-Year Change | 44.98% |
| Day's Range | 3.57 - 3.91 |
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Close | Change | Change (%) | Open | High | Low |
|---|---|---|---|---|---|---|
| Jul 25, 2024 | 3.77 | 0.30 | 8.65% | 3.47 | 4.06 | 3.37 |
| Jul 24, 2024 | 3.57 | -0.02 | -0.56% | 3.59 | 3.87 | 3.32 |
| Jul 23, 2024 | 3.72 | -0.69 | -15.65% | 4.41 | 4.88 | 3.39 |
| Jul 22, 2024 | 4.45 | 0.08 | 1.83% | 4.37 | 4.47 | 4.18 |
| Jul 19, 2024 | 4.47 | 0.15 | 3.47% | 4.32 | 4.55 | 4.11 |
| Jul 18, 2024 | 4.18 | -0.50 | -10.68% | 4.68 | 4.77 | 3.73 |
| Jul 17, 2024 | 4.62 | 0.16 | 3.59% | 4.46 | 4.93 | 4.19 |
| Jul 16, 2024 | 4.53 | -0.04 | -0.88% | 4.57 | 4.77 | 4.05 |
| Jul 15, 2024 | 4.60 | -0.43 | -8.55% | 5.03 | 5.03 | 4.53 |
| Jul 12, 2024 | 5.06 | -0.54 | -9.64% | 5.60 | 5.61 | 5.00 |
| Jul 11, 2024 | 5.68 | -0.10 | -1.73% | 5.78 | 5.88 | 5.58 |
| Jul 10, 2024 | 5.93 | 0.49 | 9.01% | 5.44 | 5.98 | 5.42 |
| Jul 9, 2024 | 5.48 | 0.01 | 0.18% | 5.47 | 5.53 | 5.21 |
| Jul 8, 2024 | 5.52 | 0.51 | 10.18% | 5.01 | 5.67 | 4.90 |
| Jul 5, 2024 | 4.97 | 0.29 | 6.20% | 4.68 | 5.12 | 4.68 |
| Jul 3, 2024 | 0.55 | 0.00 | 0.00% | 0.55 | 0.56 | 0.53 |
| Jul 2, 2024 | 0.58 | -0.07 | -10.77% | 0.65 | 0.65 | 0.54 |
| Jul 1, 2024 | 0.65 | -0.03 | -4.41% | 0.68 | 0.68 | 0.64 |
| Jun 28, 2024 | 0.66 | 0.02 | 3.13% | 0.64 | 0.69 | 0.63 |
| Jun 27, 2024 | 0.66 | -0.02 | -2.94% | 0.68 | 0.68 | 0.62 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 20
- 100
- 500
- 1000
- 10000
Phio Pharmaceuticals Corp. Company profile
About Phio Pharmaceuticals Corp
Phio Pharmaceuticals Corp. is a biotechnology company. The Company is focused on developing immuno-oncology therapeutics based on its self-delivering ribonucleic acid interface (RNAi) INTASYL therapeutic platform. The Company has developed a product platform based on its INTASYL technology that allows selective non-genetically modified programming of adoptive cell therapy (ACT) cells and of the tumor micro-environment (TME), resulting in reduced immune inhibition and in improved immunotherapy. Its lead product candidate, PH-762, is an INTASYL compound that targets the checkpoint protein PD-1, which acts as a type of switch that prevents T cells from attacking certain cells, such as cancer cells, in the body. Its second product candidate, PH-894, is an INTASYL compound that targets BRD4, which is a regulator of gene expression impacting cell differentiation. It is also developing PH-804, which targets the suppressive immune receptor TIGIT.
Financial summary
BRIEF: For the nine months ended 30 September 2021, Phio Pharmaceuticals Corp revenues was not reported. Net loss increased 55% to $9.8M. Higher net loss reflects Research & Development Expenses - Balanc increase from $3.2M to $7M (expense), Labor & Related Expenses in SGA increase from $93K to $262K (expense), Stock-based Compensation in R&D increase from $17K to $80K (expense).
Equity composition
Common stock $.0001 Par, 1500M shares auth., 100,439,841 issd. Insider own 52.94%. 07/13, 1-for-30 reverse stock split. 04/16, 1-for-10 reverse stock split.
| Industry: | Biotechnology & Medical Research (NEC) |
257 Simarano Dr Ste 101
MARLBOROUGH
MASSACHUSETTS 01752-3070
US
News
How to manage risk when trading
Learn what risk management is and find out how understanding about it could help you identify potential risks in your investment portfolio. Find out more.
06:57, 22 July 2024
ECB preview: lack of new data sees markets expecting a hold
Markets expect the ECB to keep rates unchanged in July but expectations for a September cut rise
13:13, 18 July 2024
What is an IPO and how does it work?
Learn about what an IPO is, why they are important, and how they work.
07:19, 10 July 2024
What are the biggest stock exchanges worldwide?
Discover the largest stock exchanges in the world by market capitalisation, including the Nasdaq Stock Market, the New York Stock Exchange and the London Stock Exchange.
12:44, 9 July 2024
Top ETFs
ETFs, or exchange-traded funds, offer traders a versatile gateway into the financial markets.
16:23, 8 July 2024
Lloyds forecast: will Lloyds share price return to £1? Third party data forecast
What’s next for Lloyds amid higher inflation and the start of a potential recessionary cycle in the UK?
14:00, 8 July 2024
RBNZ Preview: OCR expected to remain unchanged as central bank focuses on inflation
The Reserve Bank of New Zealand meets on Wednesday, July 10, 2024. We preview what to expect from the meeting and its possible impact on the NZD/USD.
13:25, 8 July 2024People also watch
Still looking for a broker you can trust?
Join the 630,000+ traders worldwide that chose to trade with Capital.com